secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001437749-25-017239
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DiaMedica shareholders elect all 7 director nominees, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- Michael Giuffre, Rick Kuntz, Tanya Lewis, Daniel O'Connor, James Parsons, Rick Pauls, Charles Semba elected with 96.3% or more of votes cast.
- Appointment of Baker Tilly US, LLP as auditor for FY2025 approved with 95.5% of votes cast.
- Advisory vote on executive compensation passed with 94.1% of votes cast (excluding broker non-votes).
- Quorum reached with 45.1% of outstanding shares (19.34M of 42.86M) present at May 15, 2025 AGM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774925017239/0001437749-25-017239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774925017239/dmtp20250515_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-017239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer